Barrow, Hanley, Mewhinney & Strauss’s CRH CRH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $86.2M | Sell |
819,709
-4,521
| -0.5% | -$531K | 0.28% | 88 |
|
|
2025
Q4 | $103M | Sell |
824,230
-2,024,937
| -71% | -$241M | 0.34% | 76 |
|
|
2025
Q3 | $342M | Sell |
2,849,167
-22,845
| -0.8% | -$2.41M | 1.09% | 40 |
|
|
2025
Q2 | $264M | Sell |
2,872,012
-1,593,467
| -36% | -$145M | 0.89% | 48 |
|
|
2025
Q1 | $393M | Sell |
4,465,479
-466,057
| -9% | -$45.8M | 1.43% | 27 |
|
|
2024
Q4 | $456M | Sell |
4,931,536
-562,807
| -10% | -$54.2M | 1.55% | 19 |
|
|
2024
Q3 | $510M | Buy |
5,494,343
+4,859
| +0.1% | +$408K | 1.67% | 18 |
|
|
2024
Q2 | $412M | Sell |
5,489,484
-9,723
| -0.2% | -$776K | 1.4% | 30 |
|
|
2024
Q1 | $474M | Buy |
5,499,207
+297,557
| +6% | +$22.7M | 1.6% | 22 |
|
|
2023
Q4 | $360M | Buy |
5,201,650
+1,303,074
| +33% | +$78.6M | 1.27% | 35 |
|
|
2023
Q3 | $213M | Buy |
3,898,576
+1,994,622
| +105% | +$113M | 0.82% | 44 |
|
|
2023
Q2 | $106M | Sell |
1,903,954
-33,950
| -2% | -$1.69M | 0.4% | 63 |
|
|
2023
Q1 | $98.6M | Buy |
+1,937,904
| New | +$91.8M | 0.38% | 63 |
|
|
2018
Q3 | – | Sell |
-2,344,419
| Closed | -$82.9M | – | 406 |
|
|
2018
Q2 | $82.9M | Sell |
2,344,419
-104,087
| -4% | -$3.75M | 0.13% | 112 |
|
|
2018
Q1 | $83.3M | Sell |
2,448,506
-58,400
| -2% | -$2.07M | 0.13% | 105 |
|
|
2017
Q4 | $90.5M | Sell |
2,506,906
-1,045,419
| -29% | -$37.4M | 0.14% | 107 |
|
|
2017
Q3 | $134M | Sell |
3,552,325
-560,031
| -14% | -$19.8M | 0.2% | 85 |
|
|
2017
Q2 | $146M | Sell |
4,112,356
-1,066,109
| -21% | -$38.3M | 0.22% | 85 |
|
|
2017
Q1 | $182M | Sell |
5,178,465
-1,547,020
| -23% | -$53.8M | 0.27% | 77 |
|
|
2016
Q4 | $231M | Sell |
6,725,485
-12,443,194
| -65% | -$414M | 0.35% | 68 |
|
|
2016
Q3 | $638M | Sell |
19,168,679
-8,429,558
| -31% | -$267M | 0.97% | 38 |
|
|
2016
Q2 | $816M | Sell |
27,598,237
-832,709
| -3% | -$24.4M | 1.24% | 35 |
|
|
2016
Q1 | $801M | Buy |
28,430,946
+166,361
| +0.6% | +$4.41M | 1.23% | 33 |
|
|
2015
Q4 | $815M | Sell |
28,264,585
-252,357
| -0.9% | -$7.07M | 1.21% | 33 |
|
|
2015
Q3 | $757M | Sell |
28,516,942
-1,920,237
| -6% | -$55.6M | 1.16% | 34 |
|
|
2015
Q2 | $856M | Sell |
30,437,179
-347,464
| -1% | -$9.78M | 1.17% | 33 |
|
|
2015
Q1 | $806M | Buy |
30,784,643
+1,563,809
| +5% | +$40.7M | 1.09% | 35 |
|
|
2014
Q4 | $702M | Buy |
29,220,834
+7,771,593
| +36% | +$176M | 0.94% | 40 |
|
|
2014
Q3 | $489M | Buy |
21,449,241
+8,902,518
| +71% | +$215M | 0.67% | 48 |
|
|
2014
Q2 | $324M | Buy |
12,546,723
+1,314,372
| +12% | +$37.2M | 0.44% | 59 |
|
|
2014
Q1 | $317M | Buy |
11,232,351
+2,998,570
| +36% | +$82.2M | 0.45% | 54 |
|
|
2013
Q4 | $210M | Buy |
8,233,781
+67,685
| +0.8% | +$1.68M | 0.3% | 68 |
|
|
2013
Q3 | $197M | Buy |
8,166,096
+3,862,931
| +90% | +$85.1M | 0.32% | 61 |
|
|
2013
Q2 | $87.4M | Buy |
+4,303,165
| New | +$90.8M | 0.15% | 95 |
|
Other funds holding CRH
VCM
VPM
Barrow, Hanley, Mewhinney & Strauss's CRH Position: Q1 2026 in Review
Barrow, Hanley, Mewhinney & Strauss reduced its CRH (CRH) stake by 0.55% in Q1 2026, selling an estimated $531K and leaving 819,709 shares worth $86.2M. The position accounts for 0.28% of the portfolio, ranked #88.
Barrow, Hanley, Mewhinney & Strauss first reported a position in CRH in Q2 2013 and has held it in 34 quarters since. The position peaked at $856M in Q2 2015. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss held 819,709 shares of CRH worth $86.2M as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss sold 4,521 CRH shares in Q1 2026, an estimated $531K.
- CRH made up 0.28% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #88 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in CRH in Q2 2013 and has held it in 34 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's CRH position peaked at $856M in Q2 2015.
- 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.